These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14965274

  • 1. Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.
    López de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D.
    Protein Pept Lett; 2004 Feb; 11(1):15-22. PubMed ID: 14965274
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.
    Raufman JP, Singh L, Singh G, Eng J.
    J Biol Chem; 1992 Oct 25; 267(30):21432-7. PubMed ID: 1328231
    [Abstract] [Full Text] [Related]

  • 8. The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge.
    López de Maturana R, Donnelly D.
    FEBS Lett; 2002 Oct 23; 530(1-3):244-8. PubMed ID: 12387900
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD, Gault VA, Irwin N, Mooney MH, Bailey CJ, Harriott P, Greer B, Flatt PR, O'Harte FP.
    Biol Chem; 2003 Dec 23; 384(12):1543-51. PubMed ID: 14719796
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional studies of a glucagon receptor isolated from frog Rana tigrina rugulosa: implications on the molecular evolution of glucagon receptors in vertebrates.
    Ngan ES, Chow LS, Tse DL, Du X, Wei Y, Mojsov S, Chow BK.
    FEBS Lett; 1999 Sep 03; 457(3):499-504. PubMed ID: 10471837
    [Abstract] [Full Text] [Related]

  • 15. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ, Nasr NE, Sinfield JK, Paci E, Donnelly D.
    Br J Pharmacol; 2010 Aug 03; 160(8):1973-84. PubMed ID: 20649595
    [Abstract] [Full Text] [Related]

  • 16. The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
    Al-Sabah S, Donnelly D.
    FEBS Lett; 2003 Oct 23; 553(3):342-6. PubMed ID: 14572647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.
    Hjorth SA, Schwartz TW.
    Acta Physiol Scand; 1996 Jul 23; 157(3):343-5. PubMed ID: 8830889
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.